Cushing’s Syndrome and Acromegaly Treatment Market

Cushing’s Syndrome and Acromegaly Treatment Market: Introduction

• Cushing’s syndrome is cause by increased production of corticosteroid hormones, often resulting in high blood pressure and obesity. On the other hand, Acromegaly is a chronic disorder cause due to excess production of growth hormones. The global Cushing’s syndrome and Acromegaly treatment market is anticipated to expand significantly during the forecast period owing to advancements in the healthcare industry.

Key Drivers, Restrains, and Opportunities of Global Cushing’s Syndrome and Acromegaly Treatment Market

• Development of new drug therapies with minimal or no side-effects has contributed significantly to the expansion of global Cushing’s syndrome and Acromegaly treatment market. Moreover, an increase in support from governments for the treatment Cushing’s syndrome and Acromegaly is anticipated to boost the market. Governments support the treatment of these diseases through funding and by spreading awareness.
• Additionally, there has been an increase in the disposable incomes of the population in emerging countries fueling the adoption of new treatments, thereby propelling the global Cushing’s syndrome and Acromegaly treatment market. Moreover, rising prevalence of Cushing’s syndrome and Acromegaly has also boosted the market.
• Advancements in computed tomography and magnetic resonance imaging have impacted the market favorably, thus boosting the market. Furthermore, rising expenditure on healthcare facilities coupled with a high demand for non-invasive treatments has fueled the Cushing’s syndrome and Acromegaly treatment market.
• Lack in awareness regarding the disease in underdeveloped regions and a lack of purchasing power in the population of a few regions are a few factors that are likely to restrain the global Cushing’s syndrome and Acromegaly treatment market. Nonetheless, rising investment in research and development activities for the effective treatment of these conditions may create several opportunities for the global Cushing’s syndrome and Acromegaly treatment market.

North America to Capture Major Share of Global Cushing’s Syndrome and Acromegaly Treatment Market

• North America is expected to account for a major share of the global Cushing’s syndrome and Acromegaly treatment market due to high prevalence of chronic diseases among the population. Moreover, well-established healthcare infrastructure and hub for key industry players are key factors driving the Cushing’s syndrome and Acromegaly Treatment market in the region. The market in Europe is also estimated to expand exponentially during the forecast period owing to a prominent medical industry in the region. Germany is a major contributor to the expansion of the Cushing’s syndrome and Acromegaly treatment market in the region due to the presence of key market players.
• The Cushing’s syndrome and Acromegaly Treatment market in Asia Pacific is projected to expand at a rapid pace during the forecast period owing to a rise in healthcare infrastructure in the region

Key Players Operating in Global Cushing’s Syndrome and Acromegaly Treatment Market

The global Cushing’s syndrome and Acromegaly treatment market is highly concentrated due to the presence of key players. A large number of manufacturers hold major share in their respective regions. Demand for products to treat chronic diseases has increased in emerging as well as developed markets. Growth strategies adopted by leading players are likely to drive the global Cushing’s syndrome and Acromegaly treatment market.

Major players operating in the global Cushing’s syndrome and Acromegaly treatment market are listed below:

• Bristol-Myers Squibb Company
• Corcept Therapeutics
• HRA Pharma
• Ipsen Biopharmaceuticals, Inc.
• Novartis AG
• Pfizer Inc.

Global Cushing’s syndrome and Acromegaly Treatment Market: Research Scope

Global Cushing’s syndrome and Acromegaly Treatment Market, by Drug Type

• Cushing’s Syndrome Treatment
  • Glucocorticoid Receptor Inhibitors
  • Somatostatin
  • Ketoconazole HRA
  • Other Off-label
• Acromegaly Treatment
  • Somatostatin
  • Glucocorticoid Receptor Inhibitors
  • Other Off-label

Global Cushing’s syndrome and Acromegaly Treatment Market, by Distribution Channel           

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Cushing’s syndrome and Acromegaly Treatment Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa